title: Tc-99m sestamibi and In-111 pentetreotide uptake in metastatic papillary thyroid carcinoma.
abstract: Approximately 25% of metastatic and recurrent differentiated (papillary and follicular) thyroid carcinoma do not concentrate 1-131 Nal. In such cases, diagnosis can be attempted with other radiopharmaceuticals. The authors present a case of recurrent papillary thyroid carcinoma that was well visualized with Tc-99m sestamibi and In-111 pentetreotide; but only poorly visualized by I-131 Nal.
authors.affiliation: Department of Radiology, Medicine Harbor-UCLA Medical Center, Torrance 90509, USA.
authors.forename: J
authors.initials: J
authors.lastname: Lee
authors.forename: J A
authors.initials: JA
authors.lastname: Cutrone
authors.forename: C S
authors.initials: CS
authors.lastname: Marcus
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002291:Carcinoma, Papillary / Q000000981:diagnostic imaging* / Q000556:secondary*; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D007205:Indium Radioisotopes; D017256:Technetium Tc 99m Sestamibi